210 Followers on Owler

ORIG3N develops treatments for rare genetically inherited diseases with a focus on heart, liver and neurodegenerative indications...

Read more

ORIG3N develops treatments for rare genetically inherited diseases with a focus on heart, liver and neurodegenerative indications...

Read more
ORIG3N Co-Founder & CEO: Robin Y. Smith

Co-Founder & CEO

Robin Y. Smith

CEO Approval Rating

80/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
36M
Acquisitions
1

ORIG3N Competitors

1
2
3
4
5
6
7
8
9
10

ORIG3N News

ORIG3N Blogs

ORIG3N Press Releases

ORIG3N Videos

ORIG3N Headquarters

27 Drydock Avenue 3rd Floor

Boston, Massachusetts02210

800-913-6351

Driving Directions »

ORIG3N Summary

ABOUT

Overview

ORIG3N develops treatments for rare genetically inherited diseases with a focus on heart, liver and neurodegenerative indications. ORIG3N was founded in 2014. ORIG3N's headquarters is located in Boston, Massachusetts, USA 02210. ORIG3N's Co-Founder &...

CEO

ORIG3N's Co-Founder & CEO, Robin Y. Smith, currently has an approval rating of 80%. ORIG3N's primary competitors are Ultragenyx, Qrativ & Sarepta Therapeutics.

Website

orig3n.com

Investments

Recent investment data cannot be found related to ORIG3N

Frequently Asked Questions about ORIG3N

  1. When was ORIG3N founded?

    ORIG3N was founded in 2014
  2. Who is ORIG3N's CEO?

    ORIG3N's CEO is Robin Y. Smith
  3. How much revenue does ORIG3N generate?

    ORIG3N generates $3M in revenue
  4. How much funding does ORIG3N have?

    ORIG3N has historically raised $36M in funding
  1. Where is ORIG3N's headquarters?

    ORIG3N's headquarters is in Boston Massachusetts, USA
  2. How many employees does ORIG3N have?

    ORIG3N has 60 employees
  3. What sector does ORIG3N operate in?

    ORIG3N is in Biotechnology
  4. Who are ORIG3N's competitors?

    ORIG3N's top competitors are Ultragenyx, Qrativ, Sarepta Therapeutics

Trending Companies